Source: NeuroscienceNews.com
Researchers have identified potential drug targets in glioblastoma cancer stem cells, providing a new approach to treat this aggressive brain cancer. By analyzing stem cells derived from patient tumors, scientists found two primary cell subtypes responsible for tumor growth, each with unique vulnerabilities.
The discovery could lead to treatments targeting both subtypes, reducing the likelihood of tumor recurrence. This research, using CRISPR screening across a large patient sample, brings hope for more effective, personalized glioblastoma therapies. If successful, the approach could enhance treatment response and patient prognosis.
To learn more, read the full article.
Author: Anika Hazra
Leave a Reply